Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ – Get Free Report) was the recipient of a significant drop in short interest in the month of January. As of January 30th, there was short interest totaling 2,218 shares, a drop of 90.6% from the January 15th total of 23,534 shares. Currently, 0.1% of the company’s stock are short sold. Based on an average daily volume of 37,007 shares, the short-interest ratio is presently 0.1 days. Based on an average daily volume of 37,007 shares, the short-interest ratio is presently 0.1 days. Currently, 0.1% of the company’s stock are short sold.
Institutional Inflows and Outflows
A number of institutional investors have recently added to or reduced their stakes in the company. Atria Investments Inc acquired a new stake in shares of Invesco Nasdaq Biotechnology ETF in the 2nd quarter valued at $211,000. Ignite Planners LLC purchased a new position in Invesco Nasdaq Biotechnology ETF in the fourth quarter valued at $220,000. Advisory Services Network LLC purchased a new position in Invesco Nasdaq Biotechnology ETF in the third quarter valued at $52,000. GeoWealth Management LLC acquired a new stake in Invesco Nasdaq Biotechnology ETF in the third quarter valued at $451,000. Finally, Osaic Holdings Inc. lifted its holdings in Invesco Nasdaq Biotechnology ETF by 28.4% during the 2nd quarter. Osaic Holdings Inc. now owns 4,757 shares of the company’s stock worth $101,000 after buying an additional 1,052 shares during the last quarter.
Invesco Nasdaq Biotechnology ETF Stock Down 1.1%
NASDAQ IBBQ traded down $0.34 during trading hours on Tuesday, hitting $29.34. 24,620 shares of the company were exchanged, compared to its average volume of 55,230. The firm has a market cap of $73.64 million, a price-to-earnings ratio of 17.03 and a beta of 0.67. The company has a 50 day moving average of $28.89 and a two-hundred day moving average of $26.37. Invesco Nasdaq Biotechnology ETF has a 52-week low of $17.84 and a 52-week high of $30.13.
Invesco Nasdaq Biotechnology ETF Cuts Dividend
About Invesco Nasdaq Biotechnology ETF
The Invesco Nasdaq Biotechnology ETF (IBBQ) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index, a modified market-cap-weighted index of US biotechnology and pharmaceutical companies listed on the NASDAQ. IBBQ was launched on Jun 11, 2021 and is managed by Invesco.
Recommended Stories
- Five stocks we like better than Invesco Nasdaq Biotechnology ETF
- They just tried to kill gold
- Think You Missed Silver? You’re Wrong. Here’s Why.
- When to buy gold (mathematically)
- Nvidia CEO Issues Bold Tesla Call
- How to collect $500-$800 weekly (BlackRock’s system)
Receive News & Ratings for Invesco Nasdaq Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invesco Nasdaq Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.
